ADPT — Adaptogenics Health Cashflow Statement
0.000.00%
Last trade - 00:00- CA$0.57m
- CA$0.41m
Annual cashflow statement for Adaptogenics Health, fiscal year end - March 31st, CAD millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | |
|---|---|---|
| Period Length: | 12 M | 12 M |
| Source: | PROSPECTUS | ARS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Net Income/Starting Line | -0.141 | -0.266 |
| Changes in Working Capital | 0.004 | -0.006 |
| Change in Accounts Receivable | ||
| Change in Prepaid Expenses | ||
| Change in Accounts Payable | ||
| Change in Payable / Accrued Expenses | ||
| Cash from Operating Activities | -0.136 | -0.272 |
| Net Issuance / Retirement of Stock | ||
| Cash from Financing Activities | 0.67 | 0 |
| Beginning Cash Balance | ||
| Ending Cash Balance | ||
| Net Change in Cash | 0.534 | -0.272 |